Cadrenal Therapeutics, Inc.
CVKD
Revenue
0.00
0.000.00%
-Assets
5.46M
▼-1.59M▼-22.58%
3 Months ChangeLiabilities
1.46M
▲608.60k▲71.07%
3 Months ChangeFree Cash Flow
-3.53M
▼-2.33M▼-192.75%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001213900-24-090153
2024-09-25
Form 8-K
ID: 0001213900-24-081799
2024-09-05
Form 8-K
ID: 0001213900-24-076144
2024-08-20
Form 8-K
ID: 0001213900-24-070883
2024-08-16
Form 8-K
ID: 0001213900-24-069941
2024-08-08
Form 8-K
ID: 0001213900-24-066613
2024-08-07
Form 10-Q
ID: 0001213900-24-066107
2024-08-06
Form 8-K
ID: 0001213900-24-065400
2024-07-31
Form 8-K
ID: 0001013762-24-003209
2024-05-09
Form 10-Q
ID: 0001213900-24-041014